513 related articles for article (PubMed ID: 22009066)
1. EET signaling in cancer.
Panigrahy D; Greene ER; Pozzi A; Wang DW; Zeldin DC
Cancer Metastasis Rev; 2011 Dec; 30(3-4):525-40. PubMed ID: 22009066
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.
Panigrahy D; Kaipainen A; Greene ER; Huang S
Cancer Metastasis Rev; 2010 Dec; 29(4):723-35. PubMed ID: 20941528
[TBL] [Abstract][Full Text] [Related]
3. Regulation of inflammation in cancer by eicosanoids.
Greene ER; Huang S; Serhan CN; Panigrahy D
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):27-36. PubMed ID: 21864702
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of arachidonic acid by rat adrenal glomerulosa cells: synthesis of hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids.
Campbell WB; Brady MT; Rosolowsky LJ; Falck JR
Endocrinology; 1991 Apr; 128(4):2183-94. PubMed ID: 1900788
[TBL] [Abstract][Full Text] [Related]
5. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
6. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy.
Chen C; Wang DW
Curr Top Med Chem; 2013; 13(12):1454-69. PubMed ID: 23688135
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid cytochrome P450 epoxygenase pathway.
Spector AA
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
[TBL] [Abstract][Full Text] [Related]
8. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
Shahabi P; Siest G; Visvikis-siest S
Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
[TBL] [Abstract][Full Text] [Related]
9. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
[TBL] [Abstract][Full Text] [Related]
11. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964
[TBL] [Abstract][Full Text] [Related]
12. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.
Panigrahy D; Edin ML; Lee CR; Huang S; Bielenberg DR; Butterfield CE; Barnés CM; Mammoto A; Mammoto T; Luria A; Benny O; Chaponis DM; Dudley AC; Greene ER; Vergilio JA; Pietramaggiori G; Scherer-Pietramaggiori SS; Short SM; Seth M; Lih FB; Tomer KB; Yang J; Schwendener RA; Hammock BD; Falck JR; Manthati VL; Ingber DE; Kaipainen A; D'Amore PA; Kieran MW; Zeldin DC
J Clin Invest; 2012 Jan; 122(1):178-91. PubMed ID: 22182838
[TBL] [Abstract][Full Text] [Related]
13. Vascular pharmacology of epoxyeicosatrienoic acids.
Pfister SL; Gauthier KM; Campbell WB
Adv Pharmacol; 2010; 60():27-59. PubMed ID: 21081214
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
Rifkind AB; Lee C; Chang TK; Waxman DJ
Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ
J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and vascular stability in eicosanoids and cancer.
Hu J; Frömel T; Fleming I
Cancer Metastasis Rev; 2018 Sep; 37(2-3):425-438. PubMed ID: 29808461
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids.
Rand AA; Barnych B; Morisseau C; Cajka T; Lee KSS; Panigrahy D; Hammock BD
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4370-4375. PubMed ID: 28396419
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome 450 metabolites of arachidonic acid (20-HETE, 11,12-EET and 14,15-EET) promote pheochromocytoma cell growth and tumor associated angiogenesis.
Colombero C; Cárdenas S; Venara M; Martin A; Pennisi P; Barontini M; Nowicki S
Biochimie; 2020; 171-172():147-157. PubMed ID: 32105813
[TBL] [Abstract][Full Text] [Related]
19. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids.
Medhora M; Dhanasekaran A; Gruenloh SK; Dunn LK; Gabrilovich M; Falck JR; Harder DR; Jacobs ER; Pratt PF
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):19-29. PubMed ID: 17164129
[TBL] [Abstract][Full Text] [Related]
20. Epoxyeicosatrienoic acids, cell signaling and angiogenesis.
Fleming I
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):60-7. PubMed ID: 17164133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
